ELCID Investments Intrinsic Value
ELCID Investments (ELCIDIN) median intrinsic value is ₹52306.86 from 3 valuation models (range ₹40627–₹76175), vs current price ₹103505.60 — -49.5% downside (Trading Above Calculated Value), margin of safety -97.9%. For current market price and key ratios, visit ELCID Investments share price today.
ELCIDIN Valuation Methods Summary — DCF, Graham Number & P/E
ELCID Investments intrinsic value across 3 models vs current price ₹103505.60 — upside/downside and value range per method. Browse ELCIDIN complete financial for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹76175.04 | ₹60940.03 - ₹91410.05 | -26.4% | EPS: ₹6347.92, Sector P/E: 12x |
| PEG Ratio Method | growth | ₹40626.69 | ₹36564.02 - ₹44689.36 | -60.7% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹52306.86 | ₹47076.17 - ₹57537.55 | -49.5% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
ELCIDIN Intrinsic Value vs Market Price — All Valuation Models
ELCID Investments fair value range ₹40627–₹76175 vs current market price ₹103505.60 across 3 valuation models. Compare with ELCID Investments value estimation to assess whether the stock is under or overvalued.
ELCIDIN Intrinsic Value Analysis — Undervalued or Overvalued?
ELCID Investments median intrinsic value ₹52306.86, current price ₹103505.60 — Trading Above Calculated Value by 49.5%, margin of safety -97.9%.
What is the intrinsic value of ELCIDIN?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of ELCID Investments (ELCIDIN) is ₹52306.86 (median value). With the current market price of ₹103505.60, this represents a -49.5% variance from our estimated fair value.
The valuation range spans from ₹40626.69 to ₹76175.04, indicating ₹40626.69 - ₹76175.04.
Is ELCIDIN undervalued or overvalued?
Based on our multi-method analysis, ELCID Investments (ELCIDIN) appears to be trading above calculated value by approximately 49.5%.
ELCIDIN Financial Health — Key Ratios vs Industry Benchmarks
ELCID Investments financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.00 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 1.4% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 97.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.02x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
ELCIDIN Cash Flow Quality — Operating & Free Cash Flow
ELCID Investments operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹94 Cr | ₹47 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹78 Cr | ₹36 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹37 Cr | ₹24 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹61 Cr | ₹27 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹14 Cr | ₹8 Cr | Positive Free Cash Flow | 8/10 |